Announced Mon, 13 Apr · 15:23 IST
Mankind Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on April 13, 2026.
Strategic Transactions View source PDF
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.7%1-day move
₹2084.00
prior close
₹2079.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0———+1.7+1.0+2.0+2.5+5.6+10.4+13.2+15.2+14.6+20.2
Up moveDown movePending
AI summary
Mankind Pharma's Board has approved the winding-up of Mankind Pharma Lanka (Private) Limited, a wholly owned subsidiary in Sri Lanka. The closure is due to changed regulatory requirements making the anticipated business objectives no longer viable. The subsidiary had no business operations and is not a material subsidiary of the company. The board meeting lasted 15 minutes, from 3:00 PM to 3:15 PM IST on April 13, 2026.
Likely market impact
This is a routine administrative action with no material impact on the company's financials or operations, as the subsidiary was non-operational and non-material.